E3 ubiquitin-protein ligase Mdm2; p53-binding protein Mdm2; oncoprotein Mdm2; double minute 2 protein; Hdm2 (MDM2)
Jump to navigation
Jump to search
Function
- inhibits TP53/p53- & TP73/p73-mediated cell cycle arrest & apoptosis by binding its transcriptional activation domain
- functions as a ubiquitin ligase E3 in the presence of E1 & E2, toward p53 & itself
- permits the nuclear export of p53 & targets it for proteasome-mediated proteolysis
- binds p53, p73, ARF(P14), ribosomal protein L5 & specifically to RNA
- interact with RB protein & alters binding properties of the Rb pocket[2]
- interacts with E1A-associated protein EP300 & E2F1 transcription factor
- forms a ternary complex with TP53/p53 & WWOX
- interacts with CDKN2AIP, MTBP, TRBG1 & USP7
- isoform Mdm2-F does not interact with TP53/p53
- interacts with PYHIN1
- interacts with, & ubiquitinates HIV-1 Tat
- may also bind DNA with its Zn finger(s)
- phosphorylated in response to ionizing radiation (ATM-dependent)
- auto-ubiquitinated; which leads to proteasomal degradation
Structure
- region I
- region II
- contains most of a central acidic region required for interaction with ribosomal protein L5 & a putative C4-type Zn+2 finger
- RING finger domain
- coordinates two Zn+2
- interacts specifically with RNA whether or not Zn+2 is present
- mediates the heterooligomerization with MDM4
- essential for its ubiquitin ligase E3 activity toward p53 & itself
- belongs to the MDM2/MDM4 family
- contains 1 RanBP2-type Zn+2 finger
- contains 1 RING-type Zn+2 finger
- contains 1 SWIB domain
Compartment
- nucleus, nucleoplasm, nucleolus, cytoplasm
- expressed predominantly in the nucleoplasm
- interaction with p14ARF results in the localization of both proteins to the nucleolus; he nucleolar localization signals in both p14ARF & MDM2 may be necessary to allow efficient nucleolar localization of both proteins
Alternative splicing
named isoforms=10
Expression
- ubiquitous
- induced by DNA damage
Pathology
- seems to be amplified in certain tumors including soft tissue sarcomas, osteosarcomas & gliomas)
- higher frequency of splice variants lacking p53 binding domain sequences was found in late-stage & high-grade ovarian carcinoma & bladder carcinomas
- four of the splice variants show loss of p53 binding
- isoform Mdm2-A, isoform Mdm2-B, isoform Mdm2-C, isoform Mdm2-D, isoform Mdm2-E, isoform Mdm2-F & isoform Mdm2-G are observed in a range of cancers but absent in normal tissues
- MDM2 RING finger mutations that failed to ubiquitinate p53 in vitro did not target p53 for degradation when expressed in cells
More general terms
Additional terms
References
- ↑ Lane DP. Cancer. p53, guardian of the genome. Nature. 1992 Jul 2;358(6381):15-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/1614522
- ↑ 2.0 2.1 Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol. 1995 Sep;147(3):545-60. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/7677168
- ↑ Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=4193
- ↑ Atlas of genetics & cytogenetics in oncology & haematology http://atlasgeneticsoncology.org/genes/MDM2ID115ch12q15.html
- ↑ Wikipedia; Note: Mdm2 entry http://en.wikipedia.org/wiki/Mdm2
- ↑ UniProt http://www.uniprot.org/uniprot/Q00987.html